We next confirmed the increase on the CD45RAdim, CD45RARO and CD45RAdimRO in these patients (Fig 3) and investigated CD57 and CD62L expression in our cohort of multiple myeloma (MM) patients (S2 Fig). This evidence concerns the gene B3GAT1 and Miyoshi myopathy.